XML 33 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
Earnings per Share (Tables)
9 Months Ended
Sep. 30, 2013
Earnings Per Share [Abstract]  
Basic and diluted earnings per share
 
For the Three Months
Ended September 30,
 
For the Nine Months
Ended September 30,
(In millions)
2013
 
2012
 
2013
 
2012
Numerator:
 
 
 
 
 
 
 
Net income attributable to Biogen Idec Inc.
$
487.6

 
$
398.4

 
$
1,405.0

 
$
1,087.9

Denominator:
 
 
 
 
 
 
 
Weighted average number of common shares outstanding
237.1

 
236.5

 
237.1

 
238.3

Effect of dilutive securities:
 
 
 
 
 
 
 
Stock options and employee stock purchase plan
0.2

 
0.4

 
0.4

 
0.5

Time-vested restricted stock units
0.7

 
0.9

 
0.7

 
1.0

Market stock units
0.3

 
0.3

 
0.3

 
0.3

Dilutive potential common shares
1.2

 
1.6

 
1.4

 
1.8

Shares used in calculating diluted earnings per share
238.3

 
238.1

 
238.5

 
240.1